Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Enables the RTP facility to deliver fully compliant analytical testing and release services for advanced therapies from early-stage development through commercialization.
July 22, 2025
By: Charlie Sternberg
Solvias, a global provider of chemistry, manufacturing, and controls (CMC) analysis, has announced that its recently opened Center of Excellence for biologics and novel modalities in Research Triangle Park (RTP), North Carolina, is now Current Good Manufacturing Practice (cGMP) ready.
This milestone enables the RTP facility to deliver fully compliant analytical testing and release services for advanced therapies from early-stage development through commercialization.
Archie Cullen, CEO of Solvias, said, “We are delighted with the progress of our facility development in the U.S. It has been a real testament to the hard work and commitment from our teams in both the U.S. and Europe. We have also been truly fortunate to have so many U.S.-based customers supporting us in shaping the design and ensuring the right capabilities are developed. We look forward to the next few months with our core focus on supporting our customers and the incredible new therapies they are bringing to market.”
Solvias’ European labs have a track record of supporting developers of advanced modalities across the full product lifecycle. Now, with the RTP site achieving cGMP readiness, the company is extending this expertise to meet the growing demand for specialized analytical services in the U.S. To further support this growth, Solvias also announced that the site’s Phase 2 build-out, which will add an additional 30,000 square feet of advanced laboratory space, is set to open this month.
This expansion will strengthen analytical capabilities for a wide range of modalities and delivery systems, including adeno-associated virus (AAV), mRNA, monoclonal antibodies, recombinant proteins, antibody-drug conjugates (ADCs), cell therapies, peptides, and oligonucleotides.
Amale von Planta, Chief Strategy Officer at Solvias, said, “This site is more than just additional space—it is a strategic asset designed to meet the evolving challenges of modern drug development. With expanded modality support and integrated service packages, we are enabling smarter, more agile outsourcing decisions for our clients across the industry.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !